Nanobiosensors for Non-Amyloidbeta-Tau Biomarkers as Advanced Reporters of Alzheimer’s Disease

Emerging nanomaterials providing benefits in sensitivity, specificity and cost-effectiveness are being widely investigated for biosensors in the application of Alzheimer’s disease (AD) diagnosis. Core biomarkers amyloid-beta (Aβ) and Tau have been considered as key neuropathological hallmarks of AD....

Descripción completa

Detalles Bibliográficos
Autores principales: Phan, Le Minh Tu, Hoang, Thi Xoan, Vo, Thuy Anh Thu, Kim, Jae Young, Lee, Sang-Myung, Cho, Won Woo, Kim, Young Hyo, Choi, Seong Hye, Cho, Sungbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695150/
https://www.ncbi.nlm.nih.gov/pubmed/33171630
http://dx.doi.org/10.3390/diagnostics10110913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695150/
https://www.ncbi.nlm.nih.gov/pubmed/33171630
http://dx.doi.org/10.3390/diagnostics10110913

Ejemplares similares